COPD Patients
15
1
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
1 terminated out of 15 trials
87.5%
+1.0% vs benchmark
13%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
The REVIVE Pivotal Study
A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients
Determinants of the Vascular Response to Training in Chronic Obstructive Pulmonary Disease (COPD) Patients
The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD.
Effects of Pilate Versus Aerobic Exercises on Dyspnea , Functional Capacity and Anxiety Status in Patients With COPD
The Effect of Home-Based Monitoring, Exercise Training
Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Effects of Farinelli's Breathing Exercise in COPD Patients
Markers for Chronic Obstructive Pulmonary Disease (COPD)
Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease
EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients
Prognostic Value Cardiac Dysfunction Assessed by Bedside Echocardiography in Critically Ill COPD Patients Requiring Mechanical Ventilation
Mitochondrial Dysfunction and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD) Patients
Daily Activities Are Sufficient to Induce Dynamic Pulmonary Hyperinflation and Dyspnea in Chronic Obstructive Pulmonary Disease Patients
Pulmonary Arterial Pressure Response During Exercise